DK3568403T3 - Kemiske forbindelser til belægning af nanostrukturer - Google Patents

Kemiske forbindelser til belægning af nanostrukturer Download PDF

Info

Publication number
DK3568403T3
DK3568403T3 DK18700364.5T DK18700364T DK3568403T3 DK 3568403 T3 DK3568403 T3 DK 3568403T3 DK 18700364 T DK18700364 T DK 18700364T DK 3568403 T3 DK3568403 T3 DK 3568403T3
Authority
DK
Denmark
Prior art keywords
chemical compounds
coating nanostructures
nanostructures
coating
compounds
Prior art date
Application number
DK18700364.5T
Other languages
English (en)
Inventor
Oskar Axelsson
Angelo Sanzone
Original Assignee
Spago Nanomedical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spago Nanomedical Ab filed Critical Spago Nanomedical Ab
Application granted granted Critical
Publication of DK3568403T3 publication Critical patent/DK3568403T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1833—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
    • A61K49/1848—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule the small organic molecule being a silane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/336—Polymers modified by chemical after-treatment with organic compounds containing silicon
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/49—Phosphorus-containing compounds
    • C08K5/51—Phosphorus bound to oxygen
    • C08K5/53—Phosphorus bound to oxygen bound to oxygen and to carbon only
    • C08K5/5317—Phosphonic compounds, e.g. R—P(:O)(OR')2
    • C08K5/5333—Esters of phosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
DK18700364.5T 2017-01-16 2018-01-16 Kemiske forbindelser til belægning af nanostrukturer DK3568403T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17151653.7A EP3348560A1 (en) 2017-01-16 2017-01-16 Chemical compounds for coating of nanostructures
PCT/EP2018/050975 WO2018130713A1 (en) 2017-01-16 2018-01-16 Chemical compounds for coating of nanostructures

Publications (1)

Publication Number Publication Date
DK3568403T3 true DK3568403T3 (da) 2021-07-12

Family

ID=57799639

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18700364.5T DK3568403T3 (da) 2017-01-16 2018-01-16 Kemiske forbindelser til belægning af nanostrukturer

Country Status (15)

Country Link
US (1) US11401376B2 (da)
EP (2) EP3348560A1 (da)
JP (1) JP7078274B2 (da)
KR (1) KR102536477B1 (da)
CN (1) CN110191890B (da)
AU (1) AU2018208538B2 (da)
BR (1) BR112019014483B1 (da)
CA (1) CA3048552A1 (da)
DK (1) DK3568403T3 (da)
ES (1) ES2880228T3 (da)
IL (1) IL267895B2 (da)
PL (1) PL3568403T3 (da)
RU (1) RU2757904C2 (da)
WO (1) WO2018130713A1 (da)
ZA (1) ZA201904405B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7233912B2 (en) 1997-08-26 2007-06-19 Walker Digital, Llc Method and apparatus for vending a combination of products
TWI644942B (zh) * 2015-06-12 2018-12-21 日商大金工業股份有限公司 表面處理劑
EP3838967A1 (en) 2019-12-16 2021-06-23 Spago Nanomedical AB Immobilization of phenolic compounds
CN114015036A (zh) * 2021-11-01 2022-02-08 三棵树(上海)新材料研究有限公司 低粘度硅烷改性聚醚树脂及其制备方法
EP4241792A1 (en) * 2022-03-08 2023-09-13 Spago Nanomedical AB Nanostructures and applications thereof
EP4242250A1 (en) 2022-03-08 2023-09-13 Spago Nanomedical AB Compounds for coating of nanostructures
EP4241765A1 (en) * 2022-03-08 2023-09-13 Spago Nanomedical AB Globular nanostructures having an anchoring layer
EP4241793A1 (en) * 2022-03-08 2023-09-13 Spago Nanomedical AB Globular nanostructures
CN116608891B (zh) * 2023-07-20 2023-11-03 山东省科学院激光研究所 一种光纤f-p腔传感器及其制造方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310243B1 (en) 1994-09-23 2001-10-30 Nycomed Imaging As Iodinated x-ray contrast media
ES2618361T3 (es) * 2005-09-02 2017-06-21 Visen Medical, Inc. Marcadores colorantes fluorescentes que contienen sulfonamida N,N-disustituida biocompatible
US8431545B2 (en) * 2008-03-10 2013-04-30 The University Of Tokyo Copolymer including uncharged hydrophilic block and cationic polyamino acid block having hydrophobic group in part of side chains, and use thereof
WO2010048018A1 (en) * 2008-10-21 2010-04-29 Enzon Pharmaceuticals, Inc. Treatment of neuroblastoma with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
KR101252063B1 (ko) * 2011-08-25 2013-04-12 한국생산기술연구원 알콕시실릴기를 갖는 에폭시 화합물, 이의 제조 방법, 이를 포함하는 조성물과 경화물 및 이의 용도
EP2572736A1 (en) 2011-09-23 2013-03-27 Spago Imaging AB Nanostructures comprising manganese
KR101992845B1 (ko) * 2012-03-14 2019-06-27 한국생산기술연구원 알콕시실릴기를 갖는 에폭시 화합물, 이를 포함하는 조성물, 경화물, 이의 용도 및 알콕시실릴기를 갖는 에폭시 화합물의 제조방법
WO2013180203A1 (ja) * 2012-05-31 2013-12-05 株式会社カネカ 複数の反応性ケイ素基を有する末端構造を有する重合体、およびその製造方法および利用
KR101520764B1 (ko) * 2012-06-01 2015-05-15 한국생산기술연구원 알콕시실릴기를 갖는 에폭시 화합물, 무기입자를 포함하는 조성물, 경화물, 이의 용도 및 알콕시실릴기를 갖는 에폭시 화합물의 제조방법
CA2885315C (en) * 2012-10-12 2020-06-23 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
WO2014057120A1 (en) * 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
KR101755323B1 (ko) * 2014-02-19 2017-07-20 한국생산기술연구원 신규한 에폭시 화합물, 이를 포함하는 혼합물, 조성물, 경화물, 이의 제조 방법, 및 이의 용도
EP2923712A1 (en) 2014-03-28 2015-09-30 Spago Imaging AB Nanostructures and applications thereof
WO2016050210A1 (zh) * 2014-10-01 2016-04-07 厦门赛诺邦格生物科技有限公司 一种多官能化聚乙二醇衍生物及其制备方法
CN104530417B (zh) * 2014-10-01 2017-09-08 厦门赛诺邦格生物科技股份有限公司 一种多官能化h型聚乙二醇衍生物及其制备方法
EP3464789B1 (en) * 2016-06-07 2021-04-28 Welltec A/S Downhole operational tool

Also Published As

Publication number Publication date
AU2018208538B2 (en) 2021-05-20
CN110191890B (zh) 2022-11-15
JP2020507559A (ja) 2020-03-12
CA3048552A1 (en) 2018-07-19
EP3348560A1 (en) 2018-07-18
JP7078274B2 (ja) 2022-05-31
ES2880228T3 (es) 2021-11-24
RU2757904C2 (ru) 2021-10-22
BR112019014483A2 (pt) 2020-02-11
AU2018208538A1 (en) 2019-07-18
US11401376B2 (en) 2022-08-02
RU2019125812A3 (da) 2021-05-12
PL3568403T3 (pl) 2021-11-08
US20190352459A1 (en) 2019-11-21
ZA201904405B (en) 2022-09-28
BR112019014483B1 (pt) 2023-01-17
KR20190104598A (ko) 2019-09-10
CN110191890A (zh) 2019-08-30
WO2018130713A1 (en) 2018-07-19
IL267895B (en) 2022-12-01
KR102536477B1 (ko) 2023-05-25
RU2019125812A (ru) 2021-02-16
EP3568403B1 (en) 2021-04-21
IL267895B2 (en) 2023-04-01
IL267895A (en) 2019-09-26
EP3568403A1 (en) 2019-11-20

Similar Documents

Publication Publication Date Title
DK3692040T3 (da) Kemiske forbindelser
DK3568403T3 (da) Kemiske forbindelser til belægning af nanostrukturer
DK3122458T3 (da) Fremgangsmåde til beklædning af et filtersubstrat
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
GB201609602D0 (en) Chemical compounds
GB201604681D0 (en) Chemical Compounds
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
GB201604680D0 (en) Chemical Compounds
DK3137560T3 (da) Fremgangsmåde til belægning af overflader i kemiske installationer
DK3534709T3 (da) Substituerede sulfonylamider til bekæmpelse af skadedyr
DK3728585T3 (da) Hidtil ukendte fremgangsmåder til fremstilling af oligonukleotider
DK3571394T3 (da) Inertireaktion for netstabilitet
DK3112124T3 (da) Fremgangsmåde til belægning af en rørledning
DK3490938T3 (da) Fremgangsmåder til dannelse af titancatecholkomplekser
GB201614934D0 (en) Chemical compounds
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
DK3164367T3 (da) Udglatning af en coating
DK3463328T3 (da) Seladelpar til behandling af primær biliær cholangitis
DK3601785T3 (da) Belægning
DK3507282T3 (da) Fremgangsmåde til fremstilling af indolcarboxamidforbindelser
DK3339387T3 (da) Forbindelser på basis af addukter med isocyanater til belægningssammensætninger
DK3365402T3 (da) Fremgangsmåde til belægning af overflader i kemiske anlæg
DK3672941T3 (da) Pyridylpyridonforbindelser
GB201602527D0 (en) Chemical compounds
DK3589637T3 (da) Forbindelser, der er anvendelige til inhibering af ROR-GAMMA-T